Clinical Trial Update: Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a trivalent CAR-T cell therapy for acute B-lineage leukemia is currently recruiting (TRICAR-ALL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Trivalent CAR-T cell (TRICAR-ALL)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Leukemia, B-Cell | Phase 1 | Status: RECRUITING